To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes.

in the section heading, by striking “life-saving drugs” and inserting “life-saving drugs and devices”;

in the matter preceding paragraph (1) in subsection (a), by striking “a drug” and inserting “a drug or device”;

in subsection (a)(1)(C), by striking “such drug” and inserting “such drug or device”;

in the matter following paragraph (2) in subsection (a), by striking “the drug” each place it appears and inserting “the drug or device”;

in subsection (c), by striking “the drugs” and inserting “the drugs or devices”;

in the matter before paragraph (1) in subsection (g), by striking “a drug shortage of a drug described in subsection (a)” and inserting “a drug or device shortage of a drug or device described in subsection (a)”;

in subsection (g)(1), by striking “or a supplement to such an application submitted under section 505(j), that could help mitigate or prevent such shortage” and inserting “a supplement to such an application submitted under section 505(j), or a submission for clearance of a device under section 510(k), classification of a device under section 513(f)(2), or approval of a device under section 515, that could help mitigate or prevent such shortage”;

in subsection (g)(2), by striking “such drug shortage” and inserting “such drug or device shortage”;

in subsection (h), by amending paragraph (2) to read as follows:

in subsection (h)(3)(A), by striking “a drug” and inserting “a drug or device”.

in the section heading, by striking “drug shortages” and inserting “drug and device shortages”;

in subsections (a) and (b), by striking “drug shortages” each place it appears and inserting “drug and device shortages”;

in subsection (a)(2), by striking “the staff of the Center for Drug Evaluation and Research's Office of Compliance and Drug Shortage Program” and inserting “the staffs of the Center for Drug Evaluation and Research's Office of Compliance and Drug Shortage Program and the Center for Devices and Radiological Health”;

in subsection (a)(3)(B)(i), by striking “applications and supplements” and inserting “applications, supplements, and submissions”; and

in subsections (a)(5) and (c), by striking “drug shortage” and inserting “drug or device shortage”.

in the section heading, by striking “Drug Shortage List” and inserting “Drug and Device Shortage List”; and

in subsection (a), by striking “list of drugs” and inserting “list of drugs and devices”.

in the matter before paragraph (1), by striking “each drug” and inserting “each drug and device”;

by striking “the drug” each place it appears and inserting “the drug or device”;

in paragraph (1), by striking “the National Drug Code number for such drug” and inserting “the National Drug Code number for any such drug”; and

in paragraph (2), by striking “such drug” and inserting “such device”.

by striking “discontinuation” and inserting “Discontinuation”; and

by striking “discontinuance” and inserting “Discontinuance”.